Xcout IntelPhoremost competitors & alternatives
The 12 closest competitors and alternatives to Phoremost among biotechnology companies — ranked by similarity to what Phoremost actually does, not by market-cap band.
Subscribe to see Phoremost’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Phoremost
PhoreMost Ltd is a Cambridge, United Kingdom-based biotechnology and drug discovery company dedicated to turning scientific breakthroughs into life-changing cancer therapies.
Phoremost at a glance
Phoremost is a biotechnology company headquartered in United Kingdom, founded in 2014. Its most recent funding round, Series B, raised $12M in September 2024. Xcout tracks 10 named people at Phoremost, including Neil Torbett (CEO).
Phoremost leadership
- Neil TorbettCEO
- Andrew MunceyCFO
- Barbara DuncanChair / NED
- Christian DillonCSO
- Gabriel FoxCMO
- Chris TorranceFounder / NED
4 more named people on record for Phoremost, with roles, board committees and tenure — see the full roster →
Phoremost funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $12M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Phoremost competitors
Ranked by semantic similarity — how close each company is to Phoremost by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Life Sciences
Crescendo Biologics Ltd., associated with originator organization Crescendo Bioscience LLC, is a biotechnology company headquartered in Cambridge, UK. The firm develops targeted drug pipelines, particularly focusing on oncology and PSMA-positive castration-resistant prostatic cancer treatments.
Biotech
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Similar biotechnology company
Mission Therapeutics is a drug discovery and development company recognized as a global leader in targeting deubiquitylating enzymes. Founded in 2011, the firm is based at the Babraham Research Campus in Cambridge, United Kingdom.
Similar biotechnology company
Dark Blue Therapeutics is an innovative drug discovery biotechnology company based in Oxford, United Kingdom, focused on early oncology research before being acquired by Amgen.
Biotech
Sareum Holdings plc operates as a specialized pharmaceutical company, primarily focused on discovering and advancing innovative therapeutic compounds for treating both cancer and autoimmune conditions. The firm develops small-molecule drugs, utilizing its proprietary Sareum Kinase Inhibitor Library as its core drug discovery platform. Its development portfolio currently features programs targeting Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. Sareum has also forged strategic partnerships with the Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. Founded in 2003, the company is headquartered in Cambridge, United Kingdom.
Life Sciences
ImStar Therapeutics Inc. is a biotechnology company headquartered in Vancouver, British Columbia, focused on breakthrough science and drug discovery.
Similar biotechnology company
Cumulus Oncology operates Europe's first oncology biotech creation engine, identifying promising therapeutic assets and spinning out specialized companies. Headquartered in Edinburgh, Scotland, the company secured £9m in seed financing to accelerate its oncology drug development model. It employs a lean team dedicated to oncology asset creation.
Similar biotechnology company
Phoreus Biotechnology, Inc. is a privately held biotechnology company founded in 2018 and headquartered in Olathe, Kansas. The company specializes in the development of proprietary nanocarriers for targeted drug delivery and enhanced treatments.
Similar biotechnology company
Pi Therapeutics is an Israeli preclinical-stage pharmaceutical company founded in 2015 and based in Ness Ziona. The company focuses on drug discovery and develops novel modulators of protein degradation for the treatment of cancer.
Similar biotechnology company
Pharos iBio Co., Ltd. is a South Korean biotechnology company that uses artificial intelligence and big-data approaches for drug discovery and development. Its pipeline includes oncology candidates such as PHI-101, a FLT3 inhibitor being developed for acute myeloid leukemia and other cancers, serving patients with difficult-to-treat diseases and pharmaceutical development partners.
Similar biotechnology company
Avammune Therapeutics is an R&D-driven drug discovery company headquartered in Philadelphia, Pennsylvania. The company focuses on developing novel, modality-agnostic immunotherapies and cancer therapies to address high unmet medical needs in hard-to-treat solid tumors.
Biotech
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Phoremost and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Phoremostand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →